500 patients67,039 observations150 daysLIVE

Patient P-03279

Synthetic patientONX-7 · Day 94 · 25–34 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Stable
Inflammatory state
Stable
Nutritional resilience
Stable
Discontinuation risk
54%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S14
  2. Day 58 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 61 GI-04 recommendedGI Support Protocol GI-04
  4. Day 62 Patient acceptedStarted GI-04 in the companion
  5. Day 70 GI symptom burden −34% vs expectedGI Support Protocol GI-04
  6. Day 76 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 58.

Primary contributors, last 14 days
  • Treatment adherence-25
  • Toxicity+9
  • Inflammatory activity+2

What helped?

  • GI Support Protocol GI-04Day 61
    Result: symptom burden −34%
LIFE OS recommendation
Dosing / Timing Recommendation DT-01
62%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 90% showed improvement
  • median effect visible after 5 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
3.6/10
improving · +0.3 vs previous 14 d
Stress level
Daily log
5.6/10
improving · -0.4 vs previous 14 d
Pessimism score
Daily log
5.1/10
stable · +0.2 vs previous 14 d
Sleep quality
Wearable
28/100
stable · +1.5 vs previous 14 d
Libido
Daily log
2.9/10
stable · -0.1 vs previous 14 d
HRV
Wearable
61.6 ms
stable · +1.9 vs previous 14 d
Toxicity
Blood
36.8/100
worsening · +3.8 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 49 from the failing basin, 38 from restoration.

Would help
  • ME-01 Monitoring Escalation
    100% improved among 11 similar · onset 3 d · confidence 56%
  • DT-01 Dosing / Timing Recommendation
    90% improved among 10 similar · onset 5 d · confidence 56%
  • CR-01 Clinician Review
    100% improved among 5 similar · onset 5 d · confidence 56%
  • More protein
    GI -7.3 next day on high-intake days · n 25
Would not help
  • Keep lactose low
    GI +6.1 next day on high-intake days · n 20
  • Keep histamine low
    GI +5.9 next day on high-intake days · n 18
  • Keep fat low
    GI +4.2 next day on high-intake days · n 17
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -7.3supporter · 95%
  • Lactose
    +6.1detractor · 95%
  • Histamine load
    +5.9detractor · 95%
  • Dietary fat load
    +4.2detractor · 85%
  • Caffeine
    -1.1no signal · 17%
  • Alcohol
    +1.1no signal · 19%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 45
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 42
  • Autonomic recovery 45
    • WearableResting HR 80 bpm
    • WearableShort sleep window
  • Mucosal barrier integrity 40
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • WearableSleep 5.7 h, below personal baseline
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 1.9 · butyrate capacity 46/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
60 ms
Sleep
6.5 h
Steps
4,916
Resting HR
77 bpm
Daily log: GI score 42, nutritional resilience 53, adherence 62.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0313724%S0288
P-0304324%S1687
P-0301923%S1085
P-0315624%S0785
P-0300723%S0985
P-0305624%S0584
P-0314226%S1584
P-0348824%S0383
P-0308726%S0483
P-0322824%S0583
P-0304224%S1583
P-0332924%S1883